Prelude Therapeutics Incorporated
Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)
Last updated:
Abstract:
The disclosure is directed to compounds of Formula I ##STR00001## Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
Status:
Grant
Type:
Utility
Filling date:
16 Jan 2020
Issue date:
3 Aug 2021